{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:01:56Z","timestamp":1792674116320,"version":"4.5.0"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001501","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T17:17:09Z","timestamp":1201627029000},"page":"e1501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":205,"title":["Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle"],"prefix":"10.1371","volume":"3","author":[{"given":"Rick A.","family":"Bright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey J.","family":"Crevar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin R.","family":"Toapanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Steckbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan M.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pushko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gale","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence M.","family":"Tumpey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.00005-06","article-title":"Emerging respiratory viruses: challenges and vaccine strategies.","volume":"19","author":"L Gillim-Ross","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3201\/eid1201.051147","article-title":"Vaccines for pandemic influenza.","volume":"12","author":"CJ Luke","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza.","volume":"24","author":"K Subbarao","year":"2006","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.","volume":"3","author":"AL Suguitan Jr","year":"2006","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.","volume":"370","author":"I Leroux-Roels","year":"2007","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.","volume":"279","author":"K Subbarao","year":"1998","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1086\/504723","article-title":"Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.","volume":"193","author":"CL Cheung","year":"2006","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection.","volume":"353","author":"MD de Jong","year":"2005","journal-title":"N Engl J Med"},{"key":"ref9","article-title":"Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.","author":"AC Hurt","year":"2006","journal-title":"Antiviral Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus.","volume":"437","author":"QM Le","year":"2005","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMe048344","article-title":"Avian Influenza and Pandemics\u2014Research Needs and Opportunities.","volume":"352","author":"K Stohr","year":"2005","journal-title":"N Engl J Med"},{"key":"ref12","article-title":"Recommendation of Pandemic Vaccine Selection.","author":"WH Organization","year":"2006"},{"key":"ref13","article-title":"Avian influenza\u2014situation in Indonesia\u2014update 35.","author":"WH Organization","year":"2006"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice.","volume":"23","author":"P Pushko","year":"2005","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.","volume":"25","author":"RA Bright","year":"2007","journal-title":"Vaccine"},{"key":"ref16","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints.","volume":"27","author":"L Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref17","first-page":"1515","article-title":"Emerging Infectious Diseases.","volume":"11","author":"WH Organization","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref18","first-page":"193","article-title":"Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines.","volume":"39","author":"J Wood","year":"1997","journal-title":"Dev Biol Stand"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.virol.2004.07.031","article-title":"DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.","volume":"328","author":"JF Bower","year":"2004","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1570162053506937","article-title":"C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences.","volume":"3","author":"JF Bower","year":"2005","journal-title":"Curr HIV Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0042-6822(03)00008-4","article-title":"Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine.","volume":"308","author":"RA Bright","year":"2003","journal-title":"Virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0264-410X(02)00539-X","article-title":"Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins.","volume":"21","author":"JA Mitchell","year":"2003","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/77802","article-title":"C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.","volume":"1","author":"TM Ross","year":"2000","journal-title":"Nat Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.vaccine.2003.10.050","article-title":"Mouse strain-dependent differences in enhancement of immune responses by C3d.","volume":"22","author":"FR Toapanta","year":"2004","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.","volume":"366","author":"RA Bright","year":"2005","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States.","volume":"295","author":"RA Bright","year":"2006","journal-title":"JAMA"},{"key":"ref27","first-page":"159","article-title":"The immune response to influenza viruses and the problem of protection against infection, in Bascin and applied influenza research.","author":"B Askonas","year":"1982"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/503405","article-title":"The economic impact of influenza in a university hospital setting.","volume":"22","author":"TD Szucs","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02123574","article-title":"Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses.","volume":"162","author":"K Tobita","year":"1975","journal-title":"Med Microbiol Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02123572","article-title":"Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin.","volume":"162","author":"K Tobita","year":"1975","journal-title":"Med Microbiol Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0684.2006.00173.x","article-title":"Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.","volume":"35","author":"JD Steckbeck","year":"2006","journal-title":"J Med Primatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.1128\/JVI.79.19.12311-12320.2005","article-title":"Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.","volume":"79","author":"JD Steckbeck","year":"2005","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1084\/jem.147.4.1236","article-title":"Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.","volume":"147","author":"TJ Braciale","year":"1978","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.","volume":"367","author":"MA Hoelscher","year":"2006","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(97)00177-4","article-title":"Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.","volume":"210","author":"A Lalvani","year":"1997","journal-title":"J Immunol Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.2001.1799","article-title":"Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses.","volume":"210","author":"S Sambhara","year":"2001","journal-title":"Cell Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/cimm.2001.1835","article-title":"Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.","volume":"211","author":"S Sambhara","year":"2001","journal-title":"Cell Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/273238a0","article-title":"Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.","volume":"273","author":"KL Yap","year":"1978","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans.","volume":"4","author":"MR Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0042-6822(91)90978-K","article-title":"HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles.","volume":"183","author":"OK Haffar","year":"1991","journal-title":"Virology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/157016206778560018","article-title":"Lentivirus-like particles without reverse transcriptase elicit efficient immune responses.","volume":"4","author":"SP McBurney","year":"2006","journal-title":"Curr HIV Res"},{"key":"ref42","article-title":"Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.","author":"SP McBurney","year":"2006","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/aid.2006.22.99","article-title":"Elicitation of immunity to HIV type 1 Gag is determined by Gag structure.","volume":"22","author":"KR Young","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.","volume":"191","author":"P Despres","year":"2005","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.78.1.146-157.2004","article-title":"A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.","volume":"78","author":"C Lorin","year":"2004","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/320190","article-title":"A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers.","volume":"183","author":"TG Evans","year":"2001","journal-title":"J Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine.","volume":"347","author":"LA Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmv.20173","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.","volume":"74","author":"Y Asahi-Ozaki","year":"2004","journal-title":"J Med Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.1830140414","article-title":"Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.","volume":"14","author":"FY Liew","year":"1984","journal-title":"Eur J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.79892-0","article-title":"Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice.","volume":"85","author":"T Yoshikawa","year":"2004","journal-title":"J Gen Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid1102.041061","article-title":"Human disease from influenza A (H5N1), Thailand, 2004.","volume":"11","author":"T Chotpitayasunondh","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam.","volume":"350","author":"TH Tran","year":"2004","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.","volume":"351","author":"KY Yuen","year":"1998","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","volume":"12","author":"MD de Jong","year":"2006","journal-title":"Nat Med"},{"key":"ref55","first-page":"R621","article-title":"Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis.","volume":"272","author":"W Kozak","year":"1997","journal-title":"Am J Physiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N","article-title":"Pathology of fatal human infection associated with avian influenza A H5N1 virus.","volume":"63","author":"KF To","year":"2001","journal-title":"J Med Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"CY Cheung","year":"2002","journal-title":"Lancet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.160.1.322","article-title":"Mechanism of protective immunity against influenza virus infection in mice without antibodies.","volume":"160","author":"SL Epstein","year":"1998","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1074-7613(00)80573-7","article-title":"Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.","volume":"8","author":"KJ Flynn","year":"1998","journal-title":"Immunity"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1073\/pnas.96.15.8597","article-title":"In vivo proliferation of naive and memory influenza-specific CD8(+) T cells.","volume":"96","author":"KJ Flynn","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/JVI.73.2.1453-1459.1999","article-title":"Protection against a lethal avian influenza A virus in a mammalian system.","volume":"73","author":"JM Riberdy","year":"1999","journal-title":"J Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9440(10)63950-8","article-title":"Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.","volume":"158","author":"JA Wiley","year":"2001","journal-title":"Am J Pathol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.167.6.3293","article-title":"Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.","volume":"167","author":"JA Wiley","year":"2001","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0264-410X(97)00194-1","article-title":"Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.","volume":"16","author":"K Tochikubo","year":"1998","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-3083.1997.d01-159.x","article-title":"Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.","volume":"46","author":"HY Wu","year":"1997","journal-title":"Scand J Immunol"},{"key":"ref66","first-page":"357","article-title":"<italic>Nasal-associated lymphoid tissue<\/italic>.","author":"T Sminia","year":"1999"},{"key":"ref67","first-page":"369","article-title":"Patterns of lymphatic drainage in the adult laboratory rat.","volume":"109","author":"NL Tilney","year":"1971","journal-title":"J Anat"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.5694\/j.1326-5377.2006.tb00710.x","article-title":"Pandemic vaccines: promises and pitfalls.","volume":"185","author":"R Booy","year":"2006","journal-title":"Med J Aust"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial.","volume":"367","author":"JL Bresson","year":"2006","journal-title":"Lancet"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1056\/NEJMc061152","article-title":"An inactivated subvirion influenza A (H5N1) vaccine.","volume":"354","author":"D Focosi","year":"2006","journal-title":"N Engl J Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.","volume":"80","author":"W Gao","year":"2006","journal-title":"J Virol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/505225","article-title":"Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.","volume":"194","author":"EA Govorkova","year":"2006","journal-title":"J Infect Dis"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.","volume":"368","author":"J Lin","year":"2006","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.","volume":"23","author":"C Nicolson","year":"2005","journal-title":"Vaccine"},{"key":"ref75","first-page":"127","article-title":"Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza.","volume":"124","author":"C Qiao","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy.","volume":"191","author":"I Stephenson","year":"2005","journal-title":"J Infect Dis"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.virol.2006.01.044","article-title":"The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens.","volume":"351","author":"RG Webster","year":"2006","journal-title":"Virology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2002.1742","article-title":"Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.","volume":"305","author":"K Subbarao","year":"2003","journal-title":"Virology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:40:07Z","timestamp":1708526407000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001501"}},"subtitle":[],"editor":[{"given":"Mauricio","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]}}}